Live Breaking News & Updates on Perioperative Services Roundtable

Stay updated with breaking news from Perioperative services roundtable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neuropathic pain study uncovers pathophysiological mechanism and promising therapeutic target

Neuropathic pain -; abnormal hypersensitivity to stimuli -; is associated with impaired quality of life and is often poorly managed. Estimates suggest that 3 percent to 17 percent of adults suffer from neuropathic pain, including a quarter of people with diabetes and a third of people with HIV. ....

Baylor College Of Medicine , United States , Emily Henderson , Lingyong Li , Kimberley Tolias , Associate Professor , Birmingham Department , Baylor College , Neuropathic Pain , Chronic Pain , Ouse Model ,

Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study

Perioperative toripalimab plus chemotherapy significantly improved EFS and reduced risk of disease recurrence, progression events or death by 60% among resectable stage III NSCLC patients, compared to ....

United Kingdom , United States , Junshi Biosciences , Junshi Bioscience , Zhi Li , Pr Team , National Reimbursement Drug List , European Medicines Agency , Ir Team , Drug Administration , Shanghai Junshi Biosciences Co Ltd , Regulatory Agency , Neotorch Study , Southeast Asia , Biologics License Application , Breakthrough Therapy , Fast Track , Orphan Drug , Emergency Use Authorizations ,

Pre- and post-surgical immunotherapy-based treatment significantly improved lung cancer outcomes

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023. ....

United States , Emily Henderson , John Heymach , American Association For Cancer Research , Bristol Myers Squibb , Jazz Pharmaceuticals , Eli Lilly Co , Janssen Pharmaceuticals , Boehringer Ingelheim , Spectrum Pharmaceuticals , University Of Texas Md Anderson Cancer Center , Cancer Center , American Association , Cancer Research , Annual Meeting , Neck Medical Oncology , Mirati Therapeutics , Eli Lilly , Curio Science , Blueprint Medicines , Lung Cancer , Non Small Cell Lung Cancer , Small Cell Lung Cancer ,

Dr Polan on Perioperative Outcomes With Supracervical or Total Hysterectomy Plus Colorectal Resection

Rosa M. Polan, MD, discusses key data from a comparison of perioperative outcomes with supracervical and total hysterectomy performed with concurrent colorectal resection in women. ....

Rosam Polan , Wayne State University , Barbara Ann Karmanos Cancer Institute , Supracervical Hysterectomy , Total Hysterectomy , Concurrent Colorectal Resection , Cervix Retention , Retrospective Analysis , Karmanos Cancer Center , Surgical Morbidity And Mortality , Anastomotic Leak , Blood Transfusion ,

Point-of-care test identifies patients who may benefit from hypnosis interventions for pain treatment

Hypnosis is an effective treatment for pain for many individuals but determining which patients will benefit most can be challenging. Hypnotizability testing requires special training and in-person evaluation rarely available in the clinical setting. ....

United States , Danal Cortade , Jessie Markovits , Emily Henderson , Department Of Internal Medicine , School Of Engineering , Stanford School Of Medicine , Stanford University , Molecular Diagnostics , Materials Science , Hypnotic Induction Profile , Co Lead Investigator , Internal Medicine , Stanford School , Genomics Industry Focus , Molecular Diagnostics , Precision Medicine , Single Nucleotide Polymorphism ,